Actively Recruiting
Evaluation of Clinical Versus Home Introduction of Milk in Children with Non-IgE-mediated Cow's Milk Allergy ENIGMA Trial
Led by Martini Hospital Groningen · Updated on 2024-11-25
120
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the best way to introduce cow's milk to infants suspected of having a non-IgE-mediated cow's milk allergy, which is a common food allergy in babies. The study aims to determine if cow's milk introduction should be done in a hospital setting or at home, as symptoms may be mild and overlap with other illnesses. This trial compares two methods to see which can identify if an infant can tolerate cow's milk without developing symptoms. Participants are randomly assigned to one of two groups: one group receives an adjusted double-blind placebo-controlled food challenge in the hospital over two days, where cow's milk and a look-alike placebo are given on separate days. The other group introduces cow's milk at home gradually, starting with small amounts and increasing to a full bottle. After testing, if cow's milk is tolerated, unrestricted consumption is advised; if not, parents follow a gradual "milk ladder" introduction. During the study, researchers will follow up regularly to check if the milk introduction is successful and to encourage continuation if needed. They will track the number of positive or negative test results, symptoms reported, milk consumption, and healthcare use over six weeks after the test. The main outcome is assessed one week after starting the test, with total participation lasting at least six weeks for ongoing monitoring and support.
CONDITIONS
Brief Title
Clinical Versus Home Introduction of Milk in Children with Non-IgE-mediated Cow's Milk Allergy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Maximum age of eighteen months
- Suspected to be allergic to cow's milk based on medical history
You will not qualify if you...
- Older than eighteen months
- Sensitized to cow's milk confirmed by skin prick test or specific IgE
- Moderate to severe IgE-mediated symptoms within one hour after cow's milk ingestion
- Symptoms meeting FPIES criteria after cow's milk ingestion
- Using beta blockers or prednisolone
- Uncontrolled respiratory symptoms, severe eczema, or other chronic conditions preventing participation
- Parents unable to adequately report symptoms due to language or other barriers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 week
Participants undergo either a clinical double blind placebo controlled challenge test or a home introduction of cow's milk to determine allergy status.
1 to 2 visits depending on test method
Duration - 6 weeks
Participants are followed for up to 6 weeks after the test to assess milk consumption, symptoms, and healthcare use.
Regular follow-up visits during the 6 weeks
Trial Site Locations
Total: 1 location
1
Martini Hospital
Groningen, Netherlands
Actively Recruiting
Research Team
K
Kamps, MD,PhD
V
van der Pluijm, RN
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here